Date updated:04-05-2008
From Barron's 4-05-2008
Summary of the bullish and bearish positions mentioned in the April 5th, 2008 Barron's.

-
WYE
Wyeth - $48.54
- 0.00%
- $N/A
It's rare, indeed, even in today's stressed market, that the shares of a major drug company that's fast becoming such a formidable presence in biotech can be had for less than break-up value. A company, moreover, with a strong balance sheet, high margins and a stock that sells at only 12 times earnings. A company that has long been rumored a likely takeover target for a pharma giant like Pfizer (PFE) or Novartis (NVS). A company with a promising therapy for Alzheimer's that, essentially, you get free. And a company with a dividend yield of 2.7%, paying more than a five-year Treasury note while you await the final verdict on bapineuzumab, potentially "the biggest drug of all time."

-
CCL
Carnival Corp - $33.03
- +2.87%
- $32.48
The stock could rebound 50%, based on the outlook for bookings and profitability. And Carnival would get a big boost from any drop in fuel costs.

-
NOBN.VX
Nobel Biocare N - $29.90
- +1.12%
- $29.85
Nobel's shares have fallen 50% in the past year, but now look poised to rebound by as much as 505, to a split-adjusted 73.50 Swiss francs. Some big investors are buying more.

-
DRYS
Dryships Inc. - $6.35
- 0.00%
- $6.34
DryShips' stock, now in the low 60s, could fetch 80 within 18 months. In short term, however, seasickness pills are a must; the voyage could be quite choppy.

-
MU
Micron Technology - $7.46
- -0.93%
- $7.52
Last week, Micron said that it had cut its cost of goods sold in the latest quarter by 15% for DRAM and 25% for NAND flash. Nice, but not enough when prices are falling even more. But in a world of flat pricing, the economics could change quickly. Demand for memory is hardly slowing; Micron's cost cuts should leave it well-positioned to capitalize when the market turns, which some think will happen in a quarter or two. Micron will never be a huge earnings story. But, at less than $7 a share, it trades at just 70% of book value and recently fell to a 14-year low. It has $2 billion in cash. The stock looks ugly, but that's when you buy it.

-
PTEC
Phoenix Technolog - $2.67
- -4.64%
- $2.80
At close to $16, Phoenix stock trades at 80 times projected earnings for the September 2009 fiscal year, and about 6 times revenues. But Schneiderman observes that none of the new initiatives are yet in the estimates. The analyst says that Phoenix aims to grow the BIOS business to $100 million by 2011, from around $70 million this year. He suggests that the segment deserves a stock-market value of about $300 million. The company's remaining market cap is around $140 million -- the option value of the other three businesses. Schneiderman's take is that if any of those new areas gain traction, the stock could be worth more, maybe a lot more. Down the road, he envisions $200 million in revenue, with a stock at five times revenue. In other words, he sees Phoenix rising from the ashes, back to a billion-dollar valuation.

-
T
At&t Inc. - $27.08
- -0.07%
- $27.25
THE TWO LARGEST U.S. PHONE COMPANIES JUST TOOK out a lease on the future, and patient investors could do the same by buying their stocks.

-
VZ
Verizon Commun - $32.03
- +0.50%
- $31.96
THE TWO LARGEST U.S. PHONE COMPANIES JUST TOOK out a lease on the future, and patient investors could do the same by buying their stocks.
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Top 5 Small-Cap Stocks: N...
- » Echo5Joker's Portfolio
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 25, 2009 With Thanksgiving fast approaching, retailers have one thing on their collective minds: Black Friday. After all, the day, whi...
By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...
By Roberto Pedone Posted on Nov. 24, 2009 10 Terrific Dividend Stocks: This Barron’s article highlights 10 high-quality dividend-paying stocks for investors who’re ...
By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...
A. blurp, you're looking at the last sale
which i have no idea why it would be
that. what you do need to look at is
bid/ask for what it'll cost you. mike
A. The only one I own : SLX,
too hard pick a winner out all of them
Analyst Upgrades or Estimate Increases for Nov. 25, 2009. Read more here. more
Here are some of the biggest stocks that made the 52-week high list on Nov. 25, 2009. more
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more













Comments not available